[1]
C. Hong, S. Kim, G. Curnew, S. Schulman, E. Pullenayegum, and A. Holbrook, ‚ÄúVALIDATION OF A PATIENT DECISION AID FOR CHOOSING BETWEEN DABIGATRAN AND WARFARIN FOR ATRIAL FIBRILLATION‚ÄĚ, J Popl Ther Clin Pharmacol, vol. 20, no. 3, Sep. 2013.